Astena Holdings
8095.TWholesale Trade
Financials · Consolidated
| Fiscal year ended | 2025-11 | 2024-11 | 2023-11 | 2022-11 | 2021-11 | 2020-11 |
|---|---|---|---|---|---|---|
| Revenue | ¥62.7bn | ¥58.0bnr | ¥52.0bnr | ¥49.6bnr | ¥72.3bnr | ¥65.3bn |
| Operating income | ¥3.0bn | ¥2.8bnr | ¥1.1bn | ¥820m | ¥2.2bn | — |
| Ordinary income | ¥2.9bn | ¥2.8bnr | ¥1.4bnr | ¥887mr | ¥2.4bnr | ¥2.0bn |
| Net income (owners) | ¥2.2bn | −¥2.5bnr | ¥1.2bnr | ¥579mr | ¥1.7bnr | ¥2.0bn |
| Total assets | ¥75.4bn | ¥64.6bnr | ¥67.3bnr | ¥63.6bnr | ¥63.6bnr | ¥54.3bn |
| Net assets / equity | ¥27.4bn | ¥25.3bnr | ¥28.6bnr | ¥27.1bnr | ¥27.0bnr | ¥21.7bn |
| Operating cash flow | ¥3.4bn | ¥4.8bnr | ¥1.6bnr | −¥742mr | ¥1.3bnr | ¥4.1bn |
| EPS (basic) | ¥54.23 | ¥-63.18 | ¥29.47 | ¥14.56 | ¥46.86 | ¥60.33 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 5
| Period | Form | Figures |
|---|---|---|
| 2024-12-01 → 2025-11-30 | Annual | 203 figures · EDINET |
| 2023-12-01 → 2024-11-30 | Annual | 203 figures · EDINET |
| 2022-12-01 → 2023-11-30 | Annual | 203 figures · EDINET |
| 2021-12-01 → 2022-11-30 | AnnualAmended | 204 figures · EDINET |
| 2021-12-01 → 2022-11-30 | Annual | 204 figures · EDINET |
24 more reports are still being processed.
Segments · FY ended 2025-11
| Segment | External sales | Profit |
|---|---|---|
| Fine Chemicals | ¥22.3bn | ¥909m |
| Health And Beauty Care Food | ¥18.2bn | ¥700m |
| Industrial Chemicals | ¥9.7bn | ¥733m |
| Medical | ¥12.4bn | ¥1.1bn |
| Other segments | ¥57m | −¥363m |
| Adjustments & eliminations | — | −¥80m |
| Total | ¥62.7bn | ¥3.5bn |
| Total | ¥62.7bn | ¥3.1bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.